Musculoskeletal Disorders Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MESO | B | Mesoblast Limited | 1.37 | |
KROS | D | Keros Therapeutics, Inc. | -2.75 |
Related Industries: Biotechnology
Related Stock Lists:
Bone
Hematology
Skeletal Disorders
Therapeutic Products
Adult Stem Cell
Anemia
Back Pain
Biopharmaceutical
Biotechnology
Bone Disease
Bone Marrow
Cardiovascular Disease
Cell Product
Congestive Heart Failure
Degenerative Disc Disease
Diabetic Nephropathy
Disorders
Genodermatoses
Graft Versus Host Disease
Heart Failure
Related ETFs - A few ETFs which own one or more of the above listed Musculoskeletal Disorders stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 1.4 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.38 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 1.04 | |
XBI | D | SPDR S&P Biotech ETF | 0.85 | |
LABU | F | Direxion Daily S&P Biotech Bull 3X Shares | 0.63 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Bone
Hematology
Skeletal Disorders
Therapeutic Products
Adult Stem Cell
Anemia
Back Pain
Biopharmaceutical
Biotechnology
Bone Disease
Bone Marrow
Cardiovascular Disease
Cell Product
Congestive Heart Failure
Degenerative Disc Disease
Diabetic Nephropathy
Disorders
Genodermatoses
Graft Versus Host Disease
Heart Failure
- Musculoskeletal Disorders
Musculoskeletal Disorders (MSDs) are conditions that affect the muscles, bones, tendons, ligaments, and nerves of the body. They can be caused by repetitive motions, awkward postures, or overexertion. Common MSDs include carpal tunnel syndrome, tendonitis, and lower back pain. Symptoms may include pain, stiffness, swelling, and decreased range of motion. Treatment may include rest, physical therapy, medications, and surgery.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles